대한부인종양학회

최신 논문

총 게시글 : 34

Assessment of malignant potential for HPV types 16, 52, and 58 in the uterine cervix within a Korean cohort 2024-09-24 VIEW : 42
Developing a comprehensive molecular subgrouping model for cervical cancer using machine learning 2024-09-24 VIEW : 10
Initial sarcopenia and body composition changes as prognostic factors in cervical cancer patients treated with concurrent chemoradiation: An artificial intelligence-based volumetric study 2024-09-24 VIEW : 0
GX-188E DNA vaccine plus pembrolizumab in HPV 16- and/or 18-positive recurrent or advance cervical cancer: a phase 2 tria 2024-09-24 VIEW : 10
LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer 2024-06-26 VIEW : 17
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial 2024-06-26 VIEW : 5
Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelines 2024-03-29 VIEW : 36
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer 2024-03-29 VIEW : 21
Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer 2024-03-29 VIEW : 9
Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, singlearm, phase 2 trial 2024-03-29 VIEW : 5
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial 2024-03-29 VIEW : 7
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial 2023-12-26 VIEW : 12
Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer SubgroupAnalysesfromtheKEYNOTE-826RandomizedClinicalTrial 2023-12-26 VIEW : 9
Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994 / JCO 2023-09-19 VIEW : 34
Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study 2023-09-19 VIEW : 14

1
2
3